In the corporate sector, AstraZeneca (LON: AZN) stock fell 0.8% after the drugmaker agreed to buy biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results